Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Conference News TCT 2024

CONFIRM2 Shows Power of AI-QCT to Use Plaque Features to Predict CAD Events

Yael L. Maxwell

November 01, 2024

Presentation TCT 2024

High Risk Coronary Atherosclerosis Identified by AI Algorithms and Its Prognostic Timeframe for Predicting Acute Coronary Syndromes

Presenter: Seokhun Yang

October 30, 2024

Presentation TCT 2024

TCT 1009: Effect of Statin on Different Stages of Coronary Plaque Evolution Defined by Topological Data Analysis of Coronary Atherosclerosis

Presenter: Hyun Jin Ahn

October 28, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

Presentation TCT 2022

TCT 761: Multivessel Coronary Artery Thrombus in the Absence of Obstructive Coronary Atherosclerosis, a Potential Role for CCTA

Presenter: Brent Klinkhammer

September 18, 2022

Presentation TCT 2022

TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption

Presenter: Gabriele Pesarini

September 17, 2022

News Conference News TCT 2022

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Yael L. Maxwell

September 16, 2022

News Conference News TCT 2020

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Todd Neale

October 21, 2020

News Conference News TCT 2020

FFR Insights Before and After PCI: Fresh Food for Thought

Caitlin E. Cox

October 16, 2020

Presentation TCT 2017

Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples)

Presenter: Gregg W. Stone, Peter H. Stone, Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

Presenter: Gregg W. Stone, Peter H. Stone, Evan A. Stein

November 01, 2017

Presentation TCT 2017

Novel Invasive Diagnostics IV: Molecular Imaging

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, Farouc Jaffer

November 01, 2017

Presentation TCT 2017

Novel Invasive Diagnostics III: Shear Stress Approaches (Endothelial, Wall, Plaque)

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, Habib Samady

November 01, 2017

Presentation TCT 2017

Novel Invasive Diagnostics II: NIRS-Based

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, David Erlinge

November 01, 2017

Presentation TCT 2017

Novel Invasive Diagnostics I: OCT-Derived Imaging

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, Akiko Maehara

November 01, 2017

Presentation TCT 2017

Novel Noninvasive Approaches II: NaF PET

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, Bon-Kwon Koo

November 01, 2017

Presentation TCT 2017

Novel Noninvasive Approaches I: CT-Based

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, James K. Min

November 01, 2017

Presentation TCT 2017

Current State-of-the-Art: Identification of Vulnerable Patients and Plaques in Patients Undergoing Coronary Angiography

Presenter: John A. Ambrose, Y. S. Chandrashekhar, Akiko Maehara

November 01, 2017

Presentation TCT 2017

Current State-of-the-Art: Identification of Vulnerable Patients and Plaques With Noninvasive Testing

Presenter: John A. Ambrose, Y. S. Chandrashekhar, James A. Goldstein

November 01, 2017

Advertisement

CONFIRM2 Shows Power of AI-QCT to Use Plaque Features to Predict CAD Events

High Risk Coronary Atherosclerosis Identified by AI Algorithms and Its Prognostic Timeframe for Predicting Acute Coronary Syndromes

TCT 1009: Effect of Statin on Different Stages of Coronary Plaque Evolution Defined by Topological Data Analysis of Coronary Atherosclerosis

What’s Going to Be Big at TCT 2024?

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

TCT 761: Multivessel Coronary Artery Thrombus in the Absence of Obstructive Coronary Atherosclerosis, a Potential Role for CCTA

TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

FFR Insights Before and After PCI: Fresh Food for Thought

Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples)

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

Novel Invasive Diagnostics IV: Molecular Imaging

Novel Invasive Diagnostics III: Shear Stress Approaches (Endothelial, Wall, Plaque)

Novel Invasive Diagnostics II: NIRS-Based

Novel Invasive Diagnostics I: OCT-Derived Imaging

Novel Noninvasive Approaches II: NaF PET

Novel Noninvasive Approaches I: CT-Based

Current State-of-the-Art: Identification of Vulnerable Patients and Plaques in Patients Undergoing Coronary Angiography

Current State-of-the-Art: Identification of Vulnerable Patients and Plaques With Noninvasive Testing

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content